tiprankstipranks
Trending News
More News >
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market
Advertisement

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Dividend Date & History

Compare
0 Followers
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
$4.08 (7.02%)
$97.92B
9.73
+21.76%
3 Buy
3 Hold
2 Sell
Hold
$1.11 (4.09%)
$195.43B
16.68
+43.34%
12 Buy
2 Hold
0 Sell
Strong Buy
$0.65 (1.96%)
$640.27M
-0.46
-59.04%
0 Buy
1 Hold
1 Sell
Moderate Sell
$6.69 (2.37%)
$263.75B
48.82
+52.14%
9 Buy
5 Hold
2 Sell
Moderate Buy
$6.68 (4.51%)
$264.84B
17.39
-4.49%
10 Buy
5 Hold
2 Sell
Moderate Buy
$3.945 (3.18%)
$66.91B
11.38
-8.98%
11 Buy
11 Hold
0 Sell
Moderate Buy
$1.295 (7.5%)
$59.92B
13.15
+6.91%
6 Buy
0 Hold
0 Sell
Strong Buy
$2.763 (7.29%)
$8.19B
15.32
-1.37%
2 Buy
1 Hold
0 Sell
Moderate Buy
$1.92 (8.4%)
$15.87B
11.18
+8.23%
7 Buy
2 Hold
0 Sell
Strong Buy

FAQ

How much is ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's dividend?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) does not pay a dividend
When is ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H ex-dividend date?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) does not pay a dividend.
When is ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H dividend payment date?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) does not pay a dividend.
Does ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H have sufficient earnings to cover their dividend?
The ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H has paid a dividend in the last year and may provide dividends in the near future.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis